D. Irwin

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial.

G. Steger, P. Reichardt, G. Fountzilas, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek™), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trial

C. Pui, H. Kantarjian, S. Jeha, 2005, Leukemia.

Recombinant urate oxidase (rasburicase) in the prevention and treatment of malignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial

C. Pui, S. Jeha, C-H Pui, 2001, Leukemia.

Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial.

Xin Li, W. Haire, X. Li, 2001, Journal of vascular and interventional radiology : JVIR.

Costs and outcomes associated with IVF using recombinant FSH.

W. Ledger, A. Lloyd, P. Anderson, 2009, Reproductive biomedicine online.